List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 265 studies with search of: "Oligodendroglioma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
Conditions: Recurrent Anaplastic Astrocytoma;   Mixed Malignant Glioma;   Oligodendroglioma
Intervention: Drug: Irinotecan HCL
2 Active, not recruiting Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Conditions: Oligoastrocytoma, Mixed;   Anaplastic Oligodendroglioma
Intervention: Drug: Temozolomide
3 Completed Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours
Condition: Oligodendrogliomas
Intervention:
4 Recruiting Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
Conditions: Low-Grade Glioma;   Astrocytoma;   Oligodendroglioma;   Mixed Oligoastrocytoma
Intervention: Drug: RAD001
5 Active, not recruiting Prolonged Daily Temozolomide for Low-Grade Glioma
Conditions: Glioma;   Astrocytoma;   Oligodendroglioma
Intervention: Drug: Temozolomide
6 Suspended A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   GBM;   Astrocytoma;   Oligodendroglioma
Intervention: Drug: 131I-TM601
7 Completed A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Conditions: Glioma;   Glioblastoma;   Astrocytoma;   Oligodendroglioma;   Brain Neoplasm
Intervention: Drug: Motexafin Gadolinium Injection
8 Terminated A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
Conditions: Glioma;   Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Intervention: Drug: Temozolomide and O6-Benzylguanine
9 Recruiting Sorafenib in Newly Diagnosed High Grade Glioma
Conditions: High Grade Glioma;   Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligoastrocytoma;   Anaplastic Oligodendroglioma
Intervention: Drug: Sorafenib dose escalation
10 Withdrawn Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Conditions: Glioblastoma Multiforme;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Glioma
Interventions: Other: enzyme-inducing anti-epileptic drugs;   Other: enzyme-inducing anti-epileptic drugs
11 Active, not recruiting Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Conditions: Adult Central Nervous System Germ Cell Tumor;   Adult Malignant Meningioma;   Adult Medulloblastoma;   Adult Noninfiltrating Astrocytoma;   Adult Oligodendroglioma;   Adult Craniopharyngioma;   Adult Meningioma;   Brain Metastases;   Adult Ependymoma;   Adult Pineal Parenchymal Tumor;   Adult Brain Stem Glioma;   Adult Infiltrating Astrocytoma;   Mixed Gliomas;   Stage IV Peripheral Primitive Neuroectodermal Tumor
Intervention: Procedure: Sterotactic radiosurgery
12 Recruiting A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma;   Malignant Astrocytoma NOS
Intervention: Drug: Nanoliposomal CPT-11
13 Active, not recruiting Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Gliomas;   Glioblastoma Multiforme;   Recurrent Brain Tumor
Interventions: Drug: carmustine;   Drug: mercaptopurine;   Drug: streptozocin
14 Recruiting Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
15 Active, not recruiting Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: thiotepa;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
16 Active, not recruiting Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
17 Active, not recruiting Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: temozolomide
18 Active, not recruiting Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: temozolomide
19 Completed Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
20 Recruiting Combination Chemotherapy and Blood-Brain Barrier Disruption Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carboplatin;   Drug: etoposide phosphate;   Drug: mannitol;   Drug: melphalan;   Drug: sodium thiosulfate

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services